A Phase 1b, Drug-Drug Interaction Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers.

Trial Profile

A Phase 1b, Drug-Drug Interaction Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Jun 2012

At a glance

  • Drugs BMS 986094; Verapamil
  • Indications Hepatitis C; Hypertension; Viral infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 31 May 2012 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
    • 31 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 31 May 2012 Bristol-Myers Squibb added as trial company and lead trial centre as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top